PATENT CLAIM ANALYSIS

Application Number: 16270291
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "476000"]

Abstract:
Disclosed are compounds of formulae: and pharmaceutically acceptable salts thereof, wherein the variables, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , n, and m are defined herein. These compounds are useful for treating Gram-negative bacteria infections. Also disclosed are methods of making these compounds.

Claim (Index 4):
A method according to  claim 3 , wherein the Gram-negative bacteria is  Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Burkholderia cepacia, Alcaligenes xylosoxidans, Acinetobacter, Enterobacteriaceae, Haemophilus, Neisseria  species,  Francisella tularensis, Yersinia pestis, Burkholderia pseudomallei, Burkholderia mallei, Rickettsia prowazekii, Coxiella burnetti, Campylobacter jejuni, Shigella, Moraxella catarrhalis , or  Chlamydia trachomatis.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.80851
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15681894', '13820404', '14912134', '14537048', '15179751']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842482573084969
- 35 USC 102 Novelty (BERT): 0.5761359460286374
- Combined Prediction Score: 0.763437026180511
- Mean Citation Score: 438.74352400000015
- Max Citation Score: 533.58167
- Similarity Product: 333.6602850578546

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test